Frederick, United States
BioSolution Designs (BSD) is a biotechnology invention studio founded in 2020 and based in the United States. The company focuses on internally inventing technology platforms and products while spinning out independent companies to facilitate larger investments and streamline scaling of each business. BSD's main focus is on the technologies required to bring Multigenic Therapies into reality. The company's platforms, sold as tools through its wholly owned subsidiary, OspreyBio, provide the entire industry with access to next-generation technology.
Simultaneously, BSD is developing its own Multigenic Therapies, with the first one being BeatBio, a Multigenic cardiac therapeutics company. The company recently received a Seed Round investment on 04 May 2021, although the specific investors for this round have not been disclosed.
With its focus on revolutionary biotechnology in the form of Multigenic Therapies, BioSolution Designs has positioned itself at the forefront of innovation in the biotechnology industry.
